secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nexalin Technology, Inc. (NXL)
CIK:        0001527352
Form:       8-K
Filed at:   2026-05-19T20:00:16+00:00
Accession:  0001829126-26-005453
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nexalin acquires PONM digital health platform for HALO Clarity for $1.3M in stock
--------------------------------------------------------------------------------

- Acquisition of all PONM shares for $1.3M in Nexalin common stock; first tranche of 959,016 shares issued at closing.
- PONM platform, already deployed at UCSD, supports AI-integrated remote monitoring, EHR, and virtual-clinic workflows.
- Planned 160-participant FDA pivotal trial for HALO Clarity in moderate-to-severe insomnia; enrollment expected Q2 2026.
- GreenLight becomes a meaningful equity holder and enters strategic partnership for development, regulatory, and commercial support.
- Collaboration Agreement with GLV provides ongoing development services at $10,000/month for 24-month initial term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527352/000182912626005453/0001829126-26-005453-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527352/000182912626005453/nexalintec_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-005453

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer